LSB — LakeShore Biopharma Co Cashflow Statement
0.000.00%
Last trade - 00:00- $92.26m
- $131.44m
- CNY687.20m
- 18
- 56
- 47
- 35
Annual cashflow statement for LakeShore Biopharma Co, fiscal year end - March 31st, CNY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -192 | -106 | -145 |
| Depreciation | |||
| Amortisation | |||
| Deferred Taxes | |||
| Non-Cash Items | 86.5 | 21.3 | 17.9 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -187 | -125 | -92.7 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -247 | -174 | -182 |
| Capital Expenditures | -105 | -299 | -57 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 0.645 | 0.008 | 0.068 |
| Sale of Fixed Assets | |||
| Cash from Investing Activities | -104 | -299 | -57 |
| Financing Cash Flow Items | — | — | 217 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 739 | 365 | 317 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 388 | -119 | 99.3 |